Official Title
Comparative Study of COVID-19 Infection in Renal Transplant Recipients and Non Transplant Recipients
Brief Summary

Post-transplant patients with COVID-19 infection who attended Shenzhen No. 3 Hospitalfrom December 2022 to February 2023, and enrolled the general population with COVID-19infection who were hospitalized during the same period, matched by age and gender.

Detailed Description

Data collection:Age, BMI, underlying comorbidities and other basic information were
collected retrospectively from the two groups. The medical records were used to collect
information about the patients' new coronavirus infection, such as the time of onset of
symptoms, time of diagnosis, time of conversion and common symptoms such as fever, cough,
nasal congestion and runny nose, muscle aches and pains.To compare the differences of the
diagnosis and treatment of KTRs and the general population infected with Omicron

Not yet recruiting
COVID-19
Renal Transplant Infection

Other: Treatment plan

Patients with different diagnoses will get different treatment options

Eligibility Criteria

Inclusion Criteria:

Confirmed novel coronavirus infection between December 2022 to February 2023,

Exclusion Criteria:

Age less than 18; failure of the transplanted kidney before the new coronavirus
infection; exclusion of oral immunosuppressed and other types of organ transplant
recipients from the non-renal transplant population

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 65 Years
Countries
China
Locations

yingxin Fu
Shenzhen, Guangdong, China

Contacts

Yingxin Fu, MD
fuyingxin@vip.163.com

Jianyong pan, MD
075561222333
panjianyong98@163.com

Not Provided

Shenzhen Third People's Hospital
NCT Number
MeSH Terms
Infections
Communicable Diseases
COVID-19